Viewing Study NCT02966795


Ignite Creation Date: 2025-12-24 @ 2:22 PM
Ignite Modification Date: 2026-01-29 @ 4:28 PM
Study NCT ID: NCT02966795
Status: COMPLETED
Last Update Posted: 2021-07-30
First Post: 2016-11-15
Is NOT Gene Therapy: True
Has Adverse Events: True

Brief Title: A Study of of Glecaprevir/Pibrentasvir in Adults With Chronic Hepatitis C Virus (HCV) Genotype 5 or 6 Infection
Sponsor: AbbVie
Organization:

Key Dates - Follows AllAPIJSON File Order

Start Date: 2017-01-25
Start Date Type: ACTUAL
Primary Completion Date: 2018-06-06
Primary Completion Date Type: ACTUAL
Completion Date: 2018-08-29
Completion Date Type: ACTUAL
First Submit Date: 2016-11-15
First Submit QC Date: None
Study First Post Date: 2016-11-17
Study First Post Date Type: ESTIMATED
Results First Submit Date: 2019-06-06
Results First Submit QC Date: None
Results First Post Date: 2019-07-10
Results First Post Date Type: ACTUAL
Results First Post QC Date: None
Results First Post QC Date Type: None
Disp First Submit Date: None
Disp First Submit QC Date: None
Disp First Post Date: None
Disp First Post Date Type: None
Last Update Submit Date: 2021-07-14
Last Update Post Date: 2021-07-30
Last Update Post Date Type: ACTUAL